ArticleJournal of cancer research and clinical oncology2020

Overall survival benefit of continuing immune checkpoint inhibitors treatment post dissociated response in patients with advanced lung cancer.

Huijie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.